PharmiWeb.com - Global Pharma News & Resources

Biotech - Press Releases

Date Title Company
20-Sep-2022 Minoryx‘s marketing authorization application for its lead candidate leriglitazone validated by EMA for orphan indication X-linked adrenoleukodystrophy (X-ALD) Minoryx
20-Sep-2022 Coave Therapeutics to Collaborate with World-Renowned Institute of Neurodegenerative Diseases of Bordeaux to Develop Gene Therapy Programs Targeting Protein Degradation in Neurodegenerative Disorders Coave Therapeutics
20-Sep-2022 Covalab, CimCure and partners receive €1.06M EUREKA Eurostars grant to develop new combination therapy for glioblastoma Andrew Lloyd Associates
20-Sep-2022 Covalab, CimCure and partners receive €1.06M EUREKA Eurostars grant to develop new combination therapy for glioblastoma Andrew Lloyd Associates
20-Sep-2022 Rapid growth puts Australian CRO Accelagen on the map for clinical research globally Accelagen
16-Sep-2022 Alfa Chemistry Offers High-Quality Dexmedetomidine Hydrochloride Meeting CP & EP Standards Alfa Chemistry
15-Sep-2022 Novotech presented with Cell & Gene Excellence Award 2022 at 6th Cell & Gene Therapy World Asia Conference Novotech Health Holdings Pte Ltd
15-Sep-2022 Tridek-One closes a €16 million financing round to develop first-in-class immune checkpoint agonists Andrew Lloyd Associates
15-Sep-2022 TRIDEK-ONE CLOSES A €16 MILLION FINANCING ROUND TO DEVELOP FIRST-IN-CLASS IMMUNE CHECKPOINT AGONISTS Andrew Lloyd Associates
14-Sep-2022 Ayala Pharmaceuticals Presents Positive Interim Data from RINGSIDE Pivotal Phase 2/3 Trial of AL102 in Desmoid Tumors at ESMO Congress 2022 Ayala Pharmaceuticals
13-Sep-2022 ValitaCell Joins Beckman Coulter Life Sciences Beckman Coulter Life Sciences
13-Sep-2022 Ori Biotech and CTMC partner to accelerate novel cell therapy delivery Ori Biotech
13-Sep-2022 Ciliatech presents groundbreaking concept in glaucoma implants, first to bypass opening anterior eye chamber Andrew Lloyd Associates
13-Sep-2022 Bora expands its CDMO capabilities as it makes landmark acquisition of TWi Pharmaceuticals Bora Pharmaceuticals
13-Sep-2022 Alfa Chemistry Newly Releases Biological Stains for Laboratory and Diagnostic Use Alfa Chemistry
13-Sep-2022 CD Formulation: Accelerated Shelf-Life Testing to Assess Drug Stability CD Formulation
12-Sep-2022 Fierce Biotech names STORM Therapeutics as one of its “Fierce 15” Biotech Companies of 2022 Fierce Biotech
12-Sep-2022 ONCOBONE VENTURES ENTERS INTO 3 CO-OPERATION FRAMEWORK AGREEMENTS ONCOBONE
12-Sep-2022 Neuroplast receives second orphan medicinal product designation for Neuro-Cells®, paving the way for application to both chronic and trauma-induced neurodegenerative diseases Neuroplast
12-Sep-2022 Professor Melief to receive 2022 Pedro J. Romero Service to JITC Award from Society for Immunotherapy of Cancer ISA Pharmaceuticals B.V.